Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by du Toit Michael, Director. Director active across 1 company, notably Aerie Pharmaceuticals INC. In total, 4 filings have been recorded. History available since 17 June 2021. The latest transaction was filed on 21 November 2022 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Michael du Toit is a Board Member at AERIE PHARMACEUTICALS INC. With a strong background in the pharmaceutical sector, he plays a crucial role in overseeing the company's operations and strategic direction. His expertise contributes to informed decision-making that fosters growth and innovation within the company. He is involved in initiatives aimed at improving clinical and commercial outcomes.